Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study

被引:38
作者
Markovic-Denic, Ljiljana [1 ]
Zivkovic, Kristina [2 ]
Lesic, Aleksandar [2 ,3 ]
Bumbasirevic, Vesna [3 ,4 ]
Dubljanin-Raspopovic, Emilija [3 ,5 ]
Bumbasirevic, Marko [2 ,3 ]
机构
[1] Fac Med, Inst Epidemiol, Belgrade, Serbia
[2] Clin Ctr Serbia, Clin Orthopaed Surg & Traumatol, Belgrade, Serbia
[3] Univ Belgrade, Fac Med, Belgrade, Serbia
[4] Clin Ctr Serbia, Clin Anaesthesiol, Belgrade, Serbia
[5] Clin Ctr Serbia, Clin Phys Med & Rehabil, Belgrade, Serbia
关键词
MOLECULAR-WEIGHT HEPARIN; ARTHROPLASTY; EPIDEMIOLOGY; PROPHYLAXIS; THROMBOSIS; ANESTHESIA;
D O I
10.1007/s00264-011-1466-5
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Venous thromboembolism (VTE) is a common complication of orthopaedic surgery in the industrialised world; though there may be variability between population groups. This study aims to define the incidence and risk factors for symptomatic VTE following primary elective total hip and knee arthoplasty surgery in a single centre in Eastern Europe. This prospective study included 499 adult patients undergoing total hip and knee arthroplasty for symptomatic osteoarthritis over a two-year period at the Clinic of Orthopaedic Surgery and Traumatology, Belgrade. The overall rate of confirmed symptomatic VTE during hospitalisation was 2.6%. According to the univariate logistic regression, an age greater than 75 years (OR = 3.08; 95%CI = 1.01-9.65), a family history of VTE (OR = 6.61; 95% CI = 1.33-32.90), varicose veins (OR = 3.13; 95% CI = 1.03-9.48), and ischemic heart disease (OR = 4.93; 95% CI = 1.61-15.09) were significant risk factors for in-hospital VTE. A family history of VTE and ischemic heart disease were independent risk factors according to multivariate regression analysis. Preoperative initiation of pharmacological thromboprophylaxis ( = 0.03) and a longer duration of thromboprophylaxis ( = 0.001) were protective for postoperative DVT. Though thromboprophylaxis was safe, with very few patients suffering major haemorrhage or heparin-induced thrombocytopenia, there was a general reluctance by our local surgeons to use prolonged thromboprophylaxis. VTE is common following hip and knee arthroplasty surgery. Orthopaedic patients with a family history of VTE, heart failure and coronary heart disease are at a considerable risk of thromboembolic complications in the postoperative period. There may be a role for preoperative thromboprophylaxis in addition to prolonged postoperative treatment.
引用
收藏
页码:1299 / 1305
页数:7
相关论文
共 24 条
[1]   Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001 - Findings from the hip and knee registry [J].
Anderson, FA ;
Hirsh, J ;
White, K ;
Fitzgerald, RH .
CHEST, 2003, 124 (06) :349S-356S
[2]   Clinical presentation and time-course of postoperative venous thromboembolism:: Results from the RIETE Registry [J].
Arcelus, Juan Ignacio ;
Monreal, Manuel ;
Caprini, Joseph A. ;
Guisado, Javier Gutierrez ;
Soto, M. Jose ;
Nunez, Manuel Jesus ;
Alvarez, Juan Carlos .
THROMBOSIS AND HAEMOSTASIS, 2008, 99 (03) :546-551
[3]   Short versus extended thromboprophylaxis after total knee arthroplasty: A randomized comparison [J].
Barrellier, Marie-Therese ;
Lebel, Benoit ;
Parienti, Jean-Jacques ;
Mismetti, Patrick ;
Dutheil, Jean-Jacques ;
Vielpeau, Claude .
THROMBOSIS RESEARCH, 2010, 126 (04) :E298-E304
[4]  
Deitelzweig Steven B, 2008, Cleve Clin J Med, V75 Suppl 3, pS27
[5]   Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of the randomised trials [J].
Eikelboom, JW ;
Quinlan, DJ ;
Douketis, JD .
LANCET, 2001, 358 (9275) :9-15
[6]   Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement [J].
Eriksson, B. I. ;
Kakkar, A. K. ;
Turpie, A. G. G. ;
Gent, M. ;
Bandel, T. -J. ;
Homering, M. ;
Misselwitz, F. ;
Lassen, M. R. .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2009, 91B (05) :636-644
[7]   Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty [J].
Fisher, William D. .
CANADIAN JOURNAL OF SURGERY, 2011, 54 (05) :344-351
[8]   Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty [J].
Friedman, Richard J. ;
Gallus, Alexander S. ;
Cushner, Fred D. ;
FitzGerald, Gordon ;
Anderson, Frederick A., Jr. .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) :87-97
[9]   Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients [J].
Fuji, Takeshi ;
Fujita, Satoru ;
Ochi, Takahiro .
INTERNATIONAL ORTHOPAEDICS, 2008, 32 (04) :443-451
[10]   Prevention of venous thromboembolism [J].
Geerts, William H. ;
Bergqvist, David ;
Pineo, Graham F. ;
Heit, John A. ;
Samama, Charles M. ;
Lassen, Michael R. ;
Colwell, Clifford W. .
CHEST, 2008, 133 (06) :381S-453S